Researchers from Pritzker Molecular Engineering, under the guidance of Prof. Jeffrey Hubbell, demonstrated that their compound can eliminate the autoimmune response linked to multiple sclerosis. Researchers at the University of Chicago's Pritzker School of Molecular Engineering (PME) have developed

Seems that trials are already happening. As a person living with UC, this could be a game changer.

    • @deafboy@lemmy.worldEnglish
      31•1 year ago

      Not tonight, Pinky…

      phase I safety trials have already been carried out in people with celiac disease, an autoimmune disease that is associated with eating wheat, barley, and rye, and phase I safety trials are underway in multiple sclerosis.

      I know, I know. Safety studies do not judge the effectiveness, but at least they’ve actually moved on from mice to humans this time.